239 related articles for article (PubMed ID: 31164716)
1. PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis.
Saha SK; Islam SMR; Kwak KS; Rahman MS; Cho SG
Cancer Gene Ther; 2020 Apr; 27(3-4):147-167. PubMed ID: 31164716
[TBL] [Abstract][Full Text] [Related]
2. Prominins control ciliary length throughout the animal kingdom: New lessons from human prominin-1 and zebrafish prominin-3.
Jászai J; Thamm K; Karbanová J; Janich P; Fargeas CA; Huttner WB; Corbeil D
J Biol Chem; 2020 May; 295(18):6007-6022. PubMed ID: 32201384
[TBL] [Abstract][Full Text] [Related]
3.
Wu KL; Chang CY; Tsai YM; Lai JC; Hung JY; Lin YS; Tsai PH; Hsu YL
Am J Cancer Res; 2024; 14(4):1561-1576. PubMed ID: 38726259
[TBL] [Abstract][Full Text] [Related]
4. Prominin 1 Significantly Correlated with Bone Metastasis of Breast Cancer and Influenced the Patient's Prognosis.
Yu CC; Wu YN; Hu KM; Zhang SZ
Biomed Res Int; 2022; 2022():4123622. PubMed ID: 36193308
[TBL] [Abstract][Full Text] [Related]
5. Prominin-2 expression increases protrusions, decreases caveolae and inhibits Cdc42 dependent fluid phase endocytosis.
Singh RD; Schroeder AS; Scheffer L; Holicky EL; Wheatley CL; Marks DL; Pagano RE
Biochem Biophys Res Commun; 2013 May; 434(3):466-72. PubMed ID: 23583380
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of CD133/PROM1 is an independent poor prognosis factor for head and neck squamous cell carcinoma.
Hu Z; Liu H; Zhang X; Hong B; Wu Z; Li Q; Zhou C
Medicine (Baltimore); 2020 Mar; 99(11):e19491. PubMed ID: 32176088
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of PROM1 (CD133) confers poor prognosis in non-small cell lung cancer.
Qiu ZX; Zhao S; Mo XM; Li WM
Int J Clin Exp Pathol; 2015; 8(6):6589-95. PubMed ID: 26261540
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics, RNA sequencing, and targeted bisulfite sequencing analyses identify the role of PROM2 as a diagnostic and prognostic biomarker.
Uqaili AA; Usman G; Bhatti U; Nasir H; Zia R; Akram MA; Jawad FA; Farid A; AbdelGawwad MR; Almutairi SM; Elshikh MS; Hussain S; Rasheed RA
Am J Transl Res; 2023; 15(8):5389-5407. PubMed ID: 37692961
[TBL] [Abstract][Full Text] [Related]
9. Prominin 2 decreases cisplatin sensitivity in non-small cell lung cancer and is modulated by CTCC binding factor.
Tang J; Shu D; Fang Z; Yang G
Radiol Oncol; 2023 Sep; 57(3):325-336. PubMed ID: 37665741
[TBL] [Abstract][Full Text] [Related]
10. Prominin-1 (CD133) defines both stem and non-stem cell populations in CNS development and gliomas.
Holmberg Olausson K; Maire CL; Haidar S; Ling J; Learner E; Nistér M; Ligon KL
PLoS One; 2014; 9(9):e106694. PubMed ID: 25184684
[TBL] [Abstract][Full Text] [Related]
11. Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer.
Saha SK; Islam SMR; Abdullah-Al-Wadud M; Islam S; Ali F; Park KS
J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30871151
[TBL] [Abstract][Full Text] [Related]
12. CRTC2 and PROM1 expression in non-small cell lung cancer: analysis by Western blot and immunohistochemistry.
Li Y; He Y; Qiu Z; Zhou B; Shi S; Zhang K; Luo Y; Huang Q; Li W
Tumour Biol; 2014 Dec; 35(12):11719-26. PubMed ID: 25256670
[TBL] [Abstract][Full Text] [Related]
13. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation.
Zhu L; Gibson P; Currle DS; Tong Y; Richardson RJ; Bayazitov IT; Poppleton H; Zakharenko S; Ellison DW; Gilbertson RJ
Nature; 2009 Jan; 457(7229):603-7. PubMed ID: 19092805
[TBL] [Abstract][Full Text] [Related]
14. Expression of a single prominin homolog in the embryo of the model chordate Ciona intestinalis.
Russo MT; Racioppi C; Zanetti L; Ristoratore F
Gene Expr Patterns; 2014 May; 15(1):38-45. PubMed ID: 24755348
[TBL] [Abstract][Full Text] [Related]
15. Prominin 1/CD133 endothelium sustains growth of proneural glioma.
Ding BS; James D; Iyer R; Falciatori I; Hambardzumyan D; Wang S; Butler JM; Rabbany SY; Hormigo A
PLoS One; 2013; 8(4):e62150. PubMed ID: 23637986
[TBL] [Abstract][Full Text] [Related]
16. Prominin-1 Is a Novel Regulator of Autophagy in the Human Retinal Pigment Epithelium.
Bhattacharya S; Yin J; Winborn CS; Zhang Q; Yue J; Chaum E
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2366-2387. PubMed ID: 28437526
[TBL] [Abstract][Full Text] [Related]
17. PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers.
Paris J; Wilhelm C; Lebbé C; Elmallah M; Pamoukdjian F; Héraud A; Gapihan G; Walle AV; Tran VN; Hamdan D; Allayous C; Battistella M; Van Glabeke E; Lim KW; Leboeuf C; Roger S; Falgarone G; Phan AT; Bousquet G
Clin Transl Med; 2024 Mar; 14(3):e1632. PubMed ID: 38515278
[TBL] [Abstract][Full Text] [Related]
18. High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma.
Raso A; Mascelli S; Biassoni R; Nozza P; Kool M; Pistorio A; Ugolotti E; Milanaccio C; Pignatelli S; Ferraro M; Pavanello M; Ravegnani M; Cama A; Garrè ML; Capra V
Neuro Oncol; 2011 May; 13(5):500-8. PubMed ID: 21486962
[TBL] [Abstract][Full Text] [Related]
19. Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression.
Zhou L; Yu KH; Wong TL; Zhang Z; Chan CH; Loong JH; Che N; Yu HJ; Tan KV; Tong M; Ngan ES; Ho JW; Ma S
Gut; 2022 Aug; 71(8):1656-1668. PubMed ID: 34588223
[TBL] [Abstract][Full Text] [Related]
20. Prominin-1 Promotes Biliary Fibrosis Associated With Biliary Atresia.
Zagory JA; Fenlon M; Dietz W; Zhao M; Nguyen MV; Trinh P; Adoumie M; Park A; Xu J; Mahdi E; Glazier A; Malkoff N; Mavila N; Wang KS;
Hepatology; 2019 Jun; 69(6):2586-2597. PubMed ID: 30723921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
